Hanna Fredholm

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Journal article: BJS-BRITISH JOURNAL OF SURGERY. 2026;113:znag093.005
Genetic testing for breast cancer-adherence, outcomes and impact on surgical management: a quality review
Huang B; Stalbom AK; Bajalica Lagercrantz S; Fredholm H
Article: EJSO. 2024;50(11):108624
Magseed application for detecting recurrent lymph node metastasis in papillary thyroid cancer: A novel minimally invasive Approach
Shabo I; Zouzos A; Fredholm H; Branstrom R; Hoog A; Kjellman M; Ihre-Lundgren C
Journal article: BJS-BRITISH JOURNAL OF SURGERY. 2024;111:znae175.024
Phyllodes Tumours: Interdisciplinary Management Recommendations from the Stockholm Region
Lindqvist E; Fahlen M; Fredholm H; Hartman J; Karlsson F; Papakonstantinou A; Sackey H; Zouzos A
Article: ANNALS OF SURGICAL ONCOLOGY. 2024;31(2):1739-1748
Risk of Postoperative Ischemic Stroke and Myocardial Infarction in Patients Operated for Cancer
Rautiola J; Bjoerklund J; Zelic R; Edgren G; Bottai M; Nilsson M; Vincent PH; Fredholm H; Falconer H; Sjovall A; Nilsson PJ; Wiklund P; Aly M; Akre O
Article: JAMA NETWORK OPEN. 2024;7(2):e2354352
Risk of Venous Thromboembolic Events After Surgery for Cancer
Bjorklund J; Rautiola J; Zelic R; Edgren G; Bottai M; Nilsson M; Vincent PH; Fredholm H; Falconer H; Sjoevall A; Nilsson PJ; Wiklund P; Aly M; Akre O
Article: EUROPEAN JOURNAL OF ONCOLOGY NURSING. 2023;63:102285
OptiBra study, a randomized controlled trial on optimal postoperative bra support after breast cancer surgery
Backman M; Hassan-Nur M; Fridblom K; Johansson H; Fredholm H; Fredriksson I
Article: CLINICAL CANCER RESEARCH. 2023;29(3):532-540
Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial
Matikas A; Johansson H; Gryback P; Bjohle J; Acs B; Boyaci C; Lekberg T; Fredholm H; Elinder E; Margolin S; Isaksson-Friman E; Bosch A; Lindman H; Adra J; Andersson A; Agartz S; Hellstrom M; Zerdes I; Hartman J; Bergh J; Hatschek T; Foukakis T
Journal article: CANCER RESEARCH. 2022;82(4):p3-18-03-p3-18-03
Long-term outcomes for breast conservation plus radiotherapy versus mastectomy in early breast cancer after neoadjuvant systemic therapy: Results from the Swedish national breast cancer register (NKBC)
Wang K; Duinmeijer A; Matikas A; Altena R; Johansson H; Fredholm H; Foukakis T
Article: CHIRURGIA (BUCHAREST, ROMANIA : 1990). 2021;116(5):S128-S135
Local Recurrence after Treatment of Ductal Carcinoma In Situ: A Comprehensive Overview
Chiorescu A; Fredholm H; Sackey HI; Fredriksson I
Article: CHIRURGIA (BUCHAREST, ROMANIA : 1990). 2021;116(5):S7-S14
The Natural History of Ductal Carcinoma In Situ of the Breast - An Overview
Fredholm H; Chiorescu A; Fredriksson I; Sackey H
Article: JAMA ONCOLOGY. 2021;7(9):1360-1367
Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients With ERBB2-Positive Breast Cancer A Phase 2 Randomized Clinical Trial
Hatschek T; Foukakis T; Bjohle J; Lekberg T; Fredholm H; Elinder E; Bosch A; Pekar G; Lindman H; Schiza A; Einbeigi Z; Adra J; Andersson A; Carlsson L; Dreifaldt AC; Isaksson-Friman E; Agartz S; Azavedo E; Gryback P; Hellstrom M; Johansson H; Maes C; Zerdes I; Hartman J; Brandberg Y; Bergh J
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(15_suppl):590
One-year follow-up of health-related quality of life in the Swedish PREDIX HER 2 trial, evaluating docetaxel, trastuzumab sc, pertuzumab versus trastuzumab emtansine as neoadjuvant treatment of HER2 positive breast cancer.
Brandberg Y; Foukakis T; Andersson A; Bjohle J; Bosch A; Carlsson L; Einbeigi Z; Fredholm H; Isaksson-Friman E; Hellstrom M; Johansson H; Lekberg T; Lindman H; Bergh JCS; Hatschek T
Article: EUROPEAN JOURNAL OF CANCER. 2017;84:278-289
Breast cancer in young women and prognosis: How important are proliferation markers?
Fredholm H; Magnusson K; Lindstrom LS; Tobin NP; Lindman H; Bergh J; Holmberg L; Ponten F; Frisell J; Fredriksson I
Article: LAKARTIDNINGEN. 2017;114:EEIT
[Worse prognosis for young women with breast cancer].
Fredriksson I; Fredholm H
Article: BREAST CANCER RESEARCH AND TREATMENT. 2016;160(1):131-143
Long-term outcome in young women with breast cancer: a population-based study
Fredholm H; Magnusson K; Lindstrom LS; Garmo H; Falt SE; Lindman H; Bergh J; Holmberg L; Ponten F; Frisell J; Fredriksson I
Article: PLOS ONE. 2009;4(11):e7695-A46
Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment
Fredholm H; Eaker S; Frisell J; Holmberg L; Fredriksson I; Lindman H
Article: CANCER. 2000;88(12):2661-2667
Allelic loss is heterogeneous throughout the tumor in colorectal carcinoma
Lindforss U; Fredholm H; Papadogiannakis N; Gad A; Zetterquist H; Olivecrona H

Alla övriga publikationer

Preprint: MEDRXIV. 2026
Macrophage spatial polarity to T cells predicts prognosis in young women with luminal breast cancer
Mezheyeuski A; Serna G; Martín-Bernabé A; Hekmati N; Zerdes I; Dénes A; Fredholm H; Mauchanski S; Guardia X; Alonso L; De Mey L; Lahoutte T; Keyaerts M; Lindblad J; Sladoje N; Wärnberg F; Sund M; Rask G; Wadsten C; Pontén F; Micke P; Fredriksson I; Nuciforo P
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2025
Supplementary Figure S2 from Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial
Matikas A; Johansson H; Grybäck P; Bjöhle J; Acs B; Boyaci C; Lekberg T; Fredholm H; Elinder E; Margolin S; Isaksson-Friman E; Bosch A; Lindman H; Adra J; Andersson A; Agartz S; Hellström M; Zerdes I; Hartman J; Bergh J; Hatschek T; Foukakis T
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2025
Supplementary Figure S3 from Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial
Matikas A; Johansson H; Grybäck P; Bjöhle J; Acs B; Boyaci C; Lekberg T; Fredholm H; Elinder E; Margolin S; Isaksson-Friman E; Bosch A; Lindman H; Adra J; Andersson A; Agartz S; Hellström M; Zerdes I; Hartman J; Bergh J; Hatschek T; Foukakis T
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2025
Supplementary Table S3 from Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial
Matikas A; Johansson H; Grybäck P; Bjöhle J; Acs B; Boyaci C; Lekberg T; Fredholm H; Elinder E; Margolin S; Isaksson-Friman E; Bosch A; Lindman H; Adra J; Andersson A; Agartz S; Hellström M; Zerdes I; Hartman J; Bergh J; Hatschek T; Foukakis T
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2025
Supplementary Table S2 from Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial
Matikas A; Johansson H; Grybäck P; Bjöhle J; Acs B; Boyaci C; Lekberg T; Fredholm H; Elinder E; Margolin S; Isaksson-Friman E; Bosch A; Lindman H; Adra J; Andersson A; Agartz S; Hellström M; Zerdes I; Hartman J; Bergh J; Hatschek T; Foukakis T
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2025
Supplementary Figure S1 from Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial
Matikas A; Johansson H; Grybäck P; Bjöhle J; Acs B; Boyaci C; Lekberg T; Fredholm H; Elinder E; Margolin S; Isaksson-Friman E; Bosch A; Lindman H; Adra J; Andersson A; Agartz S; Hellström M; Zerdes I; Hartman J; Bergh J; Hatschek T; Foukakis T
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2025
Supplementary Table S1 from Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial
Matikas A; Johansson H; Grybäck P; Bjöhle J; Acs B; Boyaci C; Lekberg T; Fredholm H; Elinder E; Margolin S; Isaksson-Friman E; Bosch A; Lindman H; Adra J; Andersson A; Agartz S; Hellström M; Zerdes I; Hartman J; Bergh J; Hatschek T; Foukakis T
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2025
Supplementary File S1 from Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial
Matikas A; Johansson H; Grybäck P; Bjöhle J; Acs B; Boyaci C; Lekberg T; Fredholm H; Elinder E; Margolin S; Isaksson-Friman E; Bosch A; Lindman H; Adra J; Andersson A; Agartz S; Hellström M; Zerdes I; Hartman J; Bergh J; Hatschek T; Foukakis T
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2025
Data from Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial
Matikas A; Johansson H; Grybäck P; Bjöhle J; Acs B; Boyaci C; Lekberg T; Fredholm H; Elinder E; Margolin S; Isaksson-Friman E; Bosch A; Lindman H; Adra J; Andersson A; Agartz S; Hellström M; Zerdes I; Hartman J; Bergh J; Hatschek T; Foukakis T
Editorial: ANNALS OF SURGICAL ONCOLOGY. 2024;31(3):1789-1790
ASO Author Reflections: Arterial Ischemic Events Following Cancer Surgery: Where Do We Stand?
Rautiola J; Bjoerklund J; Zelic R; Edgren G; Bottai M; Nilsson M; Vincent PH; Fredholm H; Falconer H; Sjovall A; Nilsson PJ; Wiklund P; Aly M; Akre O
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Supplementary Table S3 from Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial
Matikas A; Johansson H; Grybäck P; Bjöhle J; Acs B; Boyaci C; Lekberg T; Fredholm H; Elinder E; Margolin S; Isaksson-Friman E; Bosch A; Lindman H; Adra J; Andersson A; Agartz S; Hellström M; Zerdes I; Hartman J; Bergh J; Hatschek T; Foukakis T
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Supplementary Figure S2 from Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial
Matikas A; Johansson H; Grybäck P; Bjöhle J; Acs B; Boyaci C; Lekberg T; Fredholm H; Elinder E; Margolin S; Isaksson-Friman E; Bosch A; Lindman H; Adra J; Andersson A; Agartz S; Hellström M; Zerdes I; Hartman J; Bergh J; Hatschek T; Foukakis T
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Supplementary Figure S1 from Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial
Matikas A; Johansson H; Grybäck P; Bjöhle J; Acs B; Boyaci C; Lekberg T; Fredholm H; Elinder E; Margolin S; Isaksson-Friman E; Bosch A; Lindman H; Adra J; Andersson A; Agartz S; Hellström M; Zerdes I; Hartman J; Bergh J; Hatschek T; Foukakis T
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Supplementary File S1 from Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial
Matikas A; Johansson H; Grybäck P; Bjöhle J; Acs B; Boyaci C; Lekberg T; Fredholm H; Elinder E; Margolin S; Isaksson-Friman E; Bosch A; Lindman H; Adra J; Andersson A; Agartz S; Hellström M; Zerdes I; Hartman J; Bergh J; Hatschek T; Foukakis T
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Supplementary Table S3 from Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial
Matikas A; Johansson H; Grybäck P; Bjöhle J; Acs B; Boyaci C; Lekberg T; Fredholm H; Elinder E; Margolin S; Isaksson-Friman E; Bosch A; Lindman H; Adra J; Andersson A; Agartz S; Hellström M; Zerdes I; Hartman J; Bergh J; Hatschek T; Foukakis T
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Supplementary Figure S1 from Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial
Matikas A; Johansson H; Grybäck P; Bjöhle J; Acs B; Boyaci C; Lekberg T; Fredholm H; Elinder E; Margolin S; Isaksson-Friman E; Bosch A; Lindman H; Adra J; Andersson A; Agartz S; Hellström M; Zerdes I; Hartman J; Bergh J; Hatschek T; Foukakis T
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Supplementary Table S1 from Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial
Matikas A; Johansson H; Grybäck P; Bjöhle J; Acs B; Boyaci C; Lekberg T; Fredholm H; Elinder E; Margolin S; Isaksson-Friman E; Bosch A; Lindman H; Adra J; Andersson A; Agartz S; Hellström M; Zerdes I; Hartman J; Bergh J; Hatschek T; Foukakis T
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Supplementary Figure S3 from Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial
Matikas A; Johansson H; Grybäck P; Bjöhle J; Acs B; Boyaci C; Lekberg T; Fredholm H; Elinder E; Margolin S; Isaksson-Friman E; Bosch A; Lindman H; Adra J; Andersson A; Agartz S; Hellström M; Zerdes I; Hartman J; Bergh J; Hatschek T; Foukakis T
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Supplementary File S1 from Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial
Matikas A; Johansson H; Grybäck P; Bjöhle J; Acs B; Boyaci C; Lekberg T; Fredholm H; Elinder E; Margolin S; Isaksson-Friman E; Bosch A; Lindman H; Adra J; Andersson A; Agartz S; Hellström M; Zerdes I; Hartman J; Bergh J; Hatschek T; Foukakis T
Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023
Supplementary Figure S3 from Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial
Matikas A; Johansson H; Grybäck P; Bjöhle J; Acs B; Boyaci C; Lekberg T; Fredholm H; Elinder E; Margolin S; Isaksson-Friman E; Bosch A; Lindman H; Adra J; Andersson A; Agartz S; Hellström M; Zerdes I; Hartman J; Bergh J; Hatschek T; Foukakis T
Visa fler

Anställningar

Anknuten till Forskning, Molekylär medicin och kirurgi, Karolinska Institutet, 2026-2029

Examina och utbildning

Medicine Doktorsexamen, Institutionen för molekylär medicin och kirurgi, Karolinska Institutet, 2017
Läkarexamen, Karolinska Institutet, 1997

Handledning

Handledning till doktorsexamen
- Camilla André, Breast cancer in women with previous breast implants, 2026-
- Maria Angeliki Toli, Prognostic and predictive markers after neoadjuvant therapy in breast cancer, 2023-

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Handledning

Handledning till doktorsexamen

Nyheter från KI

Kalenderhändelser från KI